Steward Partners Investment Advisory, LLC Fulcrum Therapeutics, Inc. Transaction History
Steward Partners Investment Advisory, LLC
- $9.37 Billion
- Q2 2024
A detailed history of Steward Partners Investment Advisory, LLC transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 790 shares of FULC stock, worth $2,709. This represents 0.0% of its overall portfolio holdings.
Number of Shares
790
Previous 1,673
52.78%
Holding current value
$2,709
Previous $15,000
73.33%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding FULC
# of Institutions
136Shares Held
58.8MCall Options Held
4.33MPut Options Held
309K-
Ra Capital Management, L.P. Boston, MA11.6MShares$39.8 Million1.08% of portfolio
-
Rtw Investments, LP New York, NY5.85MShares$20.1 Million0.61% of portfolio
-
Black Rock Inc. New York, NY4.8MShares$16.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.07MShares$10.5 Million0.0% of portfolio
-
Cowen And Company, LLC2.96MShares$10.2 Million0.47% of portfolio
About Fulcrum Therapeutics, Inc.
- Ticker FULC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,038,900
- Market Cap $178M
- Description
- Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...